← All diseases Cancer

Breast cancer (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (202)Meta-analysis (28)Randomized trial (137)Systematic review (22)Phase 3 Study (15)Clinical trial (672)Review article (235)Early study (phase 1 or 2) (52)Case report (259)Laboratory or animal research (69)Commentary or editorial (15)Retracted Publication (4) Studies currently recruiting participants only (50)

Filter

Publications and studies (2770)

• Optimal isolation of extracellular vesicles from pleural fluid and profiling of their microRNA cargo. (2023/10/16) ♡
• Unexpected and Rare Sites of Metastasis in Oncologic Patients. (2023/10/10) ♡
• Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study. (2023/10/09) ♡
• A Novel Albumin-Related Nutrition Biomarker Predicts Breast Cancer Prognosis in Neoadjuvant Chemotherapy: A Two-Center Cohort Study. (2023/10/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. CDK4/6 inhibitors for primary endocrine resistant HR-positive/HER2-negative metastatic breast cancer: a case report. (2023/10/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Malignant melanoma in a patient with Crohn's disease treated with ustekinumab. (2023/10/04) ♡
• [(18) F] NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer. (2023/10/04) ♡
• The impact of the COVID-19 pandemic on the health behaviours of people living with and beyond breast, prostate, and colorectal cancer-a qualitative study. (2023/10/01) ♡
• Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling. (2023/10/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Selenium modulates AR/IGF-1R/EGFR and TROP2 signaling pathways and improves cancer efficacy in murine mammary carcinoma 4T1. (2023/10/01) ♡
• Crosstalk between tumor and stroma modifies CLIC4 cargo in extracellular vesicles. (2023/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A 47-Year-Old Woman with Confusion and Weakness. (2023/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary breast rhabdomyosarcoma in a 17-year-old girl. (2023/10/01) ♡
• Significance of CA15-3 in breast carcinoma with Visceral metastases. (2023/10/01) ♡
• Survival Of Patients With Brain Metastases After Palliative Whole-Brain Radiotherapy - An Experience From A Single Institute. (2023/10/01) ♡
• A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis. (2023/09/22) ♡
• Diabetic Fibrous Mastopathy: Imaging Features With Histopathologic Correlation. (2023/09/22) ♡
• Breast Cancer Screening in High-risk Women During Pregnancy and Lactation. (2023/09/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery. (2023/09/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Toxic manifestations of alpelisib in endocrinology. Description of the clinical case]. (2023/09/17) ♡
• Effects of an Integrative Day Care Clinic Program with a Focus on Nature Therapy in a Hospital Park Setting on Quality of Life in Oncological Patients-A Non-Randomized Controlled Study. (2023/09/16) ♡
• ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure. (2023/09/15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Rationale and design of Impact-women: a randomised controlled trial of the effect of time-restricted eating, healthy eating and reduced sedentary behaviour on metabolic health during chemotherapy for early-stage breast cancer. (2023/09/14) ♡
• Combined dandelion extract and all-trans retinoic acid induces cytotoxicity in human breast cancer cells. (2023/09/12) ♡
• Antioxidant and Antiproliferative Activities of Phenolic Extracts of Eriobotrya japonica (Thunb.) Lindl. Fruits and Leaves. (2023/09/10) ♡
• Weight Management Effectiveness and Predictors of Dropout in Breast Cancer Survivors: A Retrospective Study. (2023/09/02) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. How Can Framed Mammography Screening Messages Be Optimised Persuasive for Foreign-Born Chinese American Women? (2023/09/01) ♡
• Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study. (2023/09/01) ♡
• CYP2C19*17 association with higher plasma 4-hydroxy tamoxifen in Pakistani (estrogen-positive) breast cancer patients. (2023/09/01) ♡
• Age and obesity-driven changes in the extracellular matrix of the primary tumor and metastatic site influence tumor invasion and metastatic outgrowth. (2023/08/25) ♡
• Re-education of myeloid immune cells to reduce regulatory T cell expansion and impede breast cancer progression. (2023/08/14) ♡
• MAP7D3, a novel prognostic marker for triple-negative breast cancer, drives cell invasiveness and cancer-initiating cell properties to promote metastatic progression. (2023/08/07) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Significant response to margetuximab in Chinese HER2-positive metastatic breast cancer patient who progressed after second-line targeted therapy. (2023/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report. (2023/08/01) ♡
• Nanoparticles (NPs) -mediated lnCbCMA silencing to promote EEF1a1 ubiquitination and suppress breast cancer growth and metastasis. (2023/08/01) ♡
• Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling. (2023/08/01) ♡
• Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer - Hospital-based cohort study. (2023/08/01) ♡
• Global Incidence and Risk Factors Associated With Postoperative Urinary Retention Following Elective Inguinal Hernia Repair: The Retention of Urine After Inguinal Hernia Elective Repair (RETAINER I) Study. (2023/08/01) ♡
• Treatment outcome of metastasis to the pituitary gland: a case series of 21 patients with pathological diagnosis. (2023/08/01) ♡
• Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer. (2023/08/01) ♡
• Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer: a long-term safety and overall survival update from the randomised, double-blind, placebo-controlled, phase 3 trial. (2023/07/30) ♡
• Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohort. (2023/07/26) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials. (2023/07/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Plasmacytoid Carcinoma in Gastrointestinal Tract, Rare Case Presentation. (2023/07/21) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity. (2023/07/20) ♡
• Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer. (2023/07/17) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fanconi Syndrome Associated with Long-term Treatment with Zoledronate. (2023/07/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Individualize management for advanced breast cancer with pyrotinib-based anti-HER2 therapy: a case report. (2023/07/14) ♡
• The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of Rage-prompted motility of breast cancer cells. (2023/07/12) ♡
• Enhanced Production of Nitrogenated Metabolites with Anticancer Potential in Aristolochia manshuriensis Hairy Root Cultures. (2023/07/08) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.